Evidence map›Paper›PMID 41540448›Full record

ReviewCell communication and signaling : CCS2026

Recent perspectives on macrophage memory: types, mechanisms, and characteristics in pulmonary diseases.

Shuyong Wang, Bin Wang, Yonghui Qiu, Yiwei Lu, Hongjun Gu, Bo Wang, Jiang Wang

Abstract readReview
In one paragraph

Review in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shuyong Wang *Senior Department of Tuberculosis, Chinese PLA General Hospital, Beijing, 100091, China.
Bin Wang *Department of Thoracic Surgery, the First Medical Center of Chinese, PLA General Hospital, Beijing, 100853, China.
Yonghui Qiu *Department of Thoracic Surgery, Fourth Medical Center of Chinese, PLA General Hospital, Beijing, 100048, China.
Yiwei LuDepartment of Cardiology, the First Hospital of Hebei Medical University, Shijiazhuang, 050023, China.
Hongjun GuSenior Department of Pulmonary and Critical Care Medicine, Chinese PLA General Hospital, Beijing, 100091, China.
Bo WangDepartment of Thoracic Surgery, the First Medical Center of Chinese, PLA General Hospital, Beijing, 100853, China. doctorwbb@163.com.
Jiang WangSenior Department of Pulmonary and Critical Care Medicine, Chinese PLA General Hospital, Beijing, 100091, China. albert_19891117@163.com.

Funding

National Natural Science Foundation of China 32100694Natural Science Foundation of Beijing Municipality 7222182Youth Innovation Science Foundation of PLA General Hospital 22QNCZ038
6 · The paper itself

Abstract

Innate immunity has long been viewed as lacking memory capabilities. However, an increasing number of studies are challenging this conventional immunological paradigm. In recent years, innate immune memory has been recognized as an essential component of immune defense, allowing organisms to mount either enhanced or diminished responses to previously encountered stimuli. Increasing evidence suggests that innate immune memory may underlie various lung diseases. In this regard, elucidating the mechanisms of innate immune memory in pulmonary diseases not only aids in understanding the underlying pathophysiology of pulmonary disorders but also holds significant implications for therapeutic interventions. Macrophages, as a central element of the lung’s innate immune system, represent one of the most extensively investigated cell types in terms of innate immune memory. In this review, we first outline the origin and maintenance of lung macrophage homeostasis, alongside the conceptual framework, classifications, and mechanistic underpinnings of macrophage immune memory. Subsequently, we focus on summarizing the distinctive features of macrophage immune memory across diverse lung diseases, including infections, tumors, transplantation, and other immune-related conditions. Finally, we propose potential therapeutic strategies to manage various lung diseases through modulating macrophage immune memory. We hope that these advancements in immunology will uncover novel pharmacological targets and provide valuable theoretical support for researchers to understand the pathogeneses and develop effective treatment strategies.

Indexed as

Immunologic MemoryLung DiseasesMacrophagesAnimalsHumansImmunity, InnateTrained ImmunityEpigenetic reprogrammingInnate immune memoryMacrophagesMetabolic reprogrammingPulmonary diseasesToleranceTrained immunity

Identifiers

PMID41540448
PMCPMC12874869

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.